Autoxidized linoleic acid (AL) having 800meq/kg of per oxide value and 1,700meq/kg of carbonyl value was given in repeated oral doses for 1-15 days at a daily dose of 2.5ml/kg to male Wistar rats. During the administration, the effect of AL on drug-metabolizing activity was investigated periodically in liver microsomes. The contents of cyto chrome P-450 and b5 were increased by consecutive oral doses for 3-7 days. Thereafter, the amount of cytochrome P-450 decreased gradually, but the b5 decreased slightly. Thus, after administration for 11-15 days, the cytochrome P-450 content was significantly lower but the cytochrome b5 content was rather high in comparison with the control group. The aminopyrin-N-demethylase activity was not reduced even after repeated oral doses of AL for 15 days. The activation of 2-acetyl amino fluorene (2 AAF), which the authors termed S-9 activity, gradually decreased during administration for more than 3 days, and completely disappeared after administration for 9 days.
Polyunsaturated fatty acids react with atmospheric oxygen to form first their hydroperoxide (1) and subsequently a mixture of more completely oxidized pro ducts (2) , termed secondary oxidation products (SP), such as polymers, acids, and aldehydes. These substances occur in food, although in small amounts. orally given to rats, accumulated transiently in internal organs, especially in the liver, from 6 to 24h after administration. Therefore, the effects of autoxidized fatty 
Chemicals
. Linoleic acid was of extra-pure reagent grade from Nakarai Chemical Co. (Kyoto), and its purity as determined by gas chromatography was about 95%. NADPH and NADH were purchased from the Oriental Yeast Co. (Tokyo). Bovine serum albumin, glucose-6-phosphate and glucose-6-phosphate dehydrogenase were obtained from Sigma Chemical Co. (USA). Nutrient broth and agar powder were purchased from Difco (USA). The other chemicals were of guaranteed reagent grade from Nakarai Chemical Co. (Kyoto). Pantethine (60 solution) was kindly supplied by Daiichi Seiyaku Co. (Tokyo).
Animals and diet. Male Wistar rats (JCL, Tokyo, Japan) aged 3 weeks were divided into 8 groups (6 rats/group), and were fed for one month on the diet (flea Japan Inc., Tokyo) shown in Table 1 . The drinking water contained 0.00625% pantethine. The diet and drinking water were provided ad libitum. No differences in diet and water intake were observed between the groups.
Preparation of AL. Linoleic acid (12.5ml) was poured into a 12. Changes in body and liver weights during repeated AL doses No difference in growth between the 8 groups of rats was observed during the initial pretreatment month. After AL administration, body weights in all experi mental groups were lower than those of the control groups (Fig. 2) . A gradual increase in body weight was observed in the rats in two groups (AL-15 and AL-11 days administration), although a retardation of body weight gain occurred during the first one or two days at a daily dose of 2.5ml/kg. In the rats in the other groups, Fig. 3 . Changes in liver weight (g) to 100g body weight during repeated oral doses of AL. The value at 0 days of administration is that from rats of the control group without AL administration.
although there was a considerable decrease in body weight until 3 to 4 days after the beginning of the consecutive AL doses , afterward body weights began to increase gradually. As shown in Fig. 3 , the ratio of liver weight to body weight was significantly increased by the consecutive AL administration for more than 5 days (AL-5 days; 0.001<p<0.005), compared with that of the control group. The mean of liver weight to body weight increased each day during the administration periods .
Changes in cytochrome P-450 and cytochrome b5 contents by repeated AL doses
The time course of cytochrome P-450 content was followed during repeated AL administration and the results obtained are shown in Fig. 4 . The maximal contents were observed 3 to 7 days after AL administration, and thereafter the content decreased gradually. Thus, the cytochrome P-450 content was significantly de creased by repeated AL administration for 11 (0.001<p<0.005) to 15 (p<0.001) days, compared with that of the control group. Changes in cytochrome b5 content are shown in Fig. 5 . The maximal content was observed on day 7 of AL administration, while the content of cytochrome b5 was slightly decreased by repeated AL administration for 9 to 15 days. Unlike cytochrome P-450, the cytochrome b5 content, even in rat liver microsomes of repeated AL administration T. KISHIDA, and M. NATAKE for 15 days, was appreciably higher than that of the control group .
Changes in drug-metabolizing activities on rat liver S-9 fraction The aminopyrin-N-demethylase activity in the rat liver S-9 fraction was also determined as a measure of drug-metabolizing activity. As shown in Fig . 6 , there were no significant differences in the activities between the control and the groups receiving repeated oral doses for less than 3 days. On the other hand, the activities Fig. 6 . Changes in aminopyrin-N-demethylase activity in rat liver S-9 fraction during repeated oral doses of AL. The value at 0 days of administration is that from rats of the control group without AL administration. were significantly increased by repeated oral doses of AL for more than 5 days (AL 5 days: p<0.05, AL-7 days: p<0.01) during the experiment, compared with that of control group. The metabolic activation of 2-AAF with the S-9 fraction was measured by Ames' test. The number of revertants of Salmonella typhimurium TA 1538 was used as a measure of the total drug-metabolizing activities. The activities increased with the increasing volume of the S-9 fraction in the control and single oral dose groups, as shown in Fig. 7 . The S-9 activity decreased a little by repeated oral doses of AL for 3 days, and gradually decreased with dosages for more than 5 days. The activities were lost almost completely by consecutive doses of AL for more than 9 days.
DISCUSSION
In preliminary experiments, it was recognized that a daily dose of 2.5ml/kg of AL (PV=800meq/kg and CV=1,700meq/kg) was suitable as the maximum dose level, since this dose did not decrease body weight gain due to diarrhea or anorexia in rats administered AL for 5 successive days. In addition, the effect of SP (2.0ml/kg/day; prepared by column chromatography from AL with about 75% yield) on the drug-metabolizing system was essentially similar to that of AL (2.5ml/ kg/day) administered for 5 days. Therefore, the AL was used as an autoxidized oil administered orally in the present experiment.
In the present study, periodic changes in cytochrome P-450 and b5 contents and in drug-metabolizing activities were investigated for liver microsomes from rats receiving AL for various periods. The administration period for each group was altered by changing progressively the start of AL administration with the progress of growth, and finally by decapitating all rats at the same time. In this case, it was sufficient to prepare only one control sample at the decapitation time.
As shown in Fig. 2 , the decrease in body weight that occurred immediately after the beginning of the administration of AL 9, 7, 5, 3, and 1 days was not observed in rats in two groups (11 and 15 days of administrations). These facts show that more severe effects of AL might be caused immediately when a relatively large amount of AL is suddenly given to rats with larger body weight in later growth stages. However, because the mean ratio of liver weight to body weight increased from day to day during the administration periods (Fig. 3) , it was judged that the method of the present experiment was generally well suited for study of the effects of consecutive AL doses on the drug-metabolizing system in rat liver. Figure 4 shows that the cytochrome P-450 content in rat liver microsomes increased at first (induction period) and then decreased (reduction period) by the consecutive oral dose of AL for 15 days. Now we can better explain the incompatible phenomena reported previously (5, 6) for the changes in cytochrome P-450 content by repeated AL administration. The increase and the decrease of cytochrome P-450 content by repeated AL administration previously reported probably corresponds to observations in the induction and reduction periods, respectively.
The cytochrome b5 content was increased by repeated AL administration for 3 to 7 days; afterward it scarcely decreased, unlike the cytochrome P-450 content (Fig .  5) . Patzelt-Wenczler (20) has reported that the cytochrome b5 content increased in liver microsomes of vitamin E-deficient rats, and that it was lowered by applications of vitamin E to the control level. It can be concluded from these facts that a rise of in vivo lipid peroxidation induces cytochrome b5. It seems likely that this increase of cytochrome b5 is probably due to the necessity of accelerating the desaturation of fatty acids and of protecting the microsomal membrane.
The results shown in Figs. 4 and 5 suggest that cytochrome P-450 is easier to break down than cytochrome b5 during successive oral doses of AL for relatively long periods. Jeffry et al. (21) have reported that linoleic acid hydroperoxide destroys cytochrome P-450 in microsomes without destroying cytochrome b5 in vitro. Thus, the decrease of cytochrome P-450 content might be caused by the endogenous lipid hydroperoxide from the in vivo lipid peroxidation accelerated by a large amount of exogenous AL that arose from the elongation of the dose period .
The changes in aminopyrin-N-demethylase activity do not necessarily coincide with that of the cytochrome P-450 content, as shown in Figs. 4 and 6 . Because there are multiple forms of cytochrome P-450 (22) , and it plays an essential role in N demethylation of aminopyrin, it might be scarcely damaged by consecutive AL doses for 9-15 days, although the total content of cytochrome P-450 decreases .
In the Ames' test, 2-AAF is converted into N-hydroxide by cytochrome P-450 in liver microsomes. The final mutagen is formed through deacetylation of the N hydroxide by acetyltransferase in the liver cytosol (23, 24) . To estimate the total drug-metabolizing activity, the authors calculated the number of revertants of Salmonella typhimurium TA 1538 caused by this final mutagen for the S-9 fraction prepared from each rat. Unlike the contents of cytochrome P-450 and b5, and aminopyrin-N-demethylase activity, the S-9 activity decreased gradually during consecutive oral doses of AL for 3-7 days, and was completely lost by doses for more than 9 days, although the activity did not change by administration for one day (Fig. 7) . On the basis of these facts, the authors inferred that the disappearance of S-9 activity after repeated longterm AL administration resulted from a disorder of the microsomal membrane, where cytochrome P-450 plays a central role in the hydroxylation of 2-AAF, or from the inactivation of acetyltransferase which forms the final mutagen. Further investigations are necessary to clarify these possibilities . 
